Global Long-Acting Contraceptive Pills Market Growth 2026-2032
The global Long-Acting Contraceptive Pills market size is predicted to grow from US$ 85.61 million in 2025 to US$ 182 million in 2032; it is expected to grow at a CAGR of 11.6% from 2026 to 2032.
Long-acting contraceptives are medications or devices that provide sustained contraceptive effects with a single or periodic use. These contraceptives include injectables, subdermal implants, and intrauterine devices (IUDs), which can prevent pregnancy for months to years. They are designed to offer reliable, long-term contraception without the need for daily administration, making them suitable for women seeking extended protection against pregnancy.
United States market for Long-Acting Contraceptive Pills is estimated to increase from US$ million in 2025 to US$ million by 2032, at a CAGR of % from 2026 through 2032.
China market for Long-Acting Contraceptive Pills is estimated to increase from US$ million in 2025 to US$ million by 2032, at a CAGR of % from 2026 through 2032.
Europe market for Long-Acting Contraceptive Pills is estimated to increase from US$ million in 2025 to US$ million by 2032, at a CAGR of % from 2026 through 2032.
Global key Long-Acting Contraceptive Pills players cover Zhejiang Xianju Pharmaceutical, Pfizer, Mylan, Teva Pharmaceuticals, Cipla, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2025.
LP Information, Inc. (LPI) ' newest research report, the “Long-Acting Contraceptive Pills Industry Forecast” looks at past sales and reviews total world Long-Acting Contraceptive Pills sales in 2025, providing a comprehensive analysis by region and market sector of projected Long-Acting Contraceptive Pills sales for 2026 through 2032. With Long-Acting Contraceptive Pills sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Long-Acting Contraceptive Pills industry.
This Insight Report provides a comprehensive analysis of the global Long-Acting Contraceptive Pills landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Long-Acting Contraceptive Pills portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Long-Acting Contraceptive Pills market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Long-Acting Contraceptive Pills and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Long-Acting Contraceptive Pills.
This report presents a comprehensive overview, market shares, and growth opportunities of Long-Acting Contraceptive Pills market by product type, application, key manufacturers and key regions and countries.
Segmentation by Type:
What is the 10-year outlook for the global Long-Acting Contraceptive Pills market?
What factors are driving Long-Acting Contraceptive Pills market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do Long-Acting Contraceptive Pills market opportunities vary by end market size?
How does Long-Acting Contraceptive Pills break out by Type, by Application?
The report requires updating with new data and is sent in 48 hours after order is placed.
Long-acting contraceptives are medications or devices that provide sustained contraceptive effects with a single or periodic use. These contraceptives include injectables, subdermal implants, and intrauterine devices (IUDs), which can prevent pregnancy for months to years. They are designed to offer reliable, long-term contraception without the need for daily administration, making them suitable for women seeking extended protection against pregnancy.
United States market for Long-Acting Contraceptive Pills is estimated to increase from US$ million in 2025 to US$ million by 2032, at a CAGR of % from 2026 through 2032.
China market for Long-Acting Contraceptive Pills is estimated to increase from US$ million in 2025 to US$ million by 2032, at a CAGR of % from 2026 through 2032.
Europe market for Long-Acting Contraceptive Pills is estimated to increase from US$ million in 2025 to US$ million by 2032, at a CAGR of % from 2026 through 2032.
Global key Long-Acting Contraceptive Pills players cover Zhejiang Xianju Pharmaceutical, Pfizer, Mylan, Teva Pharmaceuticals, Cipla, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2025.
LP Information, Inc. (LPI) ' newest research report, the “Long-Acting Contraceptive Pills Industry Forecast” looks at past sales and reviews total world Long-Acting Contraceptive Pills sales in 2025, providing a comprehensive analysis by region and market sector of projected Long-Acting Contraceptive Pills sales for 2026 through 2032. With Long-Acting Contraceptive Pills sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Long-Acting Contraceptive Pills industry.
This Insight Report provides a comprehensive analysis of the global Long-Acting Contraceptive Pills landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Long-Acting Contraceptive Pills portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Long-Acting Contraceptive Pills market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Long-Acting Contraceptive Pills and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Long-Acting Contraceptive Pills.
This report presents a comprehensive overview, market shares, and growth opportunities of Long-Acting Contraceptive Pills market by product type, application, key manufacturers and key regions and countries.
Segmentation by Type:
- Injectables
- Subdermal Implants
- Intrauterine Devices
- Other
- Hospital
- Clinic
- Americas
- United States
- Canada
- Mexico
- Brazil
- APAC
- China
- Japan
- Korea
- Southeast Asia
- India
- Australia
- Europe
- Germany
- France
- UK
- Italy
- Russia
- Middle East & Africa
- Egypt
- South Africa
- Israel
- Turkey
- GCC Countries
- Zhejiang Xianju Pharmaceutical
- Pfizer
- Mylan
- Teva Pharmaceuticals
- Cipla
- Bayer
- Merck
- Sun Pharma
- Shanghai Pharmaceuticals
What is the 10-year outlook for the global Long-Acting Contraceptive Pills market?
What factors are driving Long-Acting Contraceptive Pills market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do Long-Acting Contraceptive Pills market opportunities vary by end market size?
How does Long-Acting Contraceptive Pills break out by Type, by Application?
The report requires updating with new data and is sent in 48 hours after order is placed.
1 SCOPE OF THE REPORT
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Long-Acting Contraceptive Pills Annual Sales 2021-2032
2.1.2 World Current & Future Analysis for Long-Acting Contraceptive Pills by Geographic Region, 2021, 2025 & 2032
2.1.3 World Current & Future Analysis for Long-Acting Contraceptive Pills by Country/Region, 2021, 2025 & 2032
2.2 Long-Acting Contraceptive Pills Segment by Type
2.2.1 Injectables
2.2.2 Subdermal Implants
2.2.3 Intrauterine Devices
2.2.4 Other
2.2.5 Long-Acting Contraceptive Pills Sales by Type
2.2.5.1 Global Long-Acting Contraceptive Pills Sales Market Share by Type (2021-2026)
2.2.5.2 Global Long-Acting Contraceptive Pills Revenue and Market Share by Type (2021-2026)
2.2.5.3 Global Long-Acting Contraceptive Pills Sale Price by Type (2021-2026)
2.3 Long-Acting Contraceptive Pills Segment by Application
2.3.1 Hospital
2.3.2 Clinic
2.3.3 Long-Acting Contraceptive Pills Sales by Application
2.3.3.1 Global Long-Acting Contraceptive Pills Sale Market Share by Application (2021-2026)
2.3.3.2 Global Long-Acting Contraceptive Pills Revenue and Market Share by Application (2021-2026)
2.3.3.3 Global Long-Acting Contraceptive Pills Sale Price by Application (2021-2026)
3 GLOBAL BY COMPANY
3.1 Global Long-Acting Contraceptive Pills Breakdown Data by Company
3.1.1 Global Long-Acting Contraceptive Pills Annual Sales by Company (2021-2026)
3.1.2 Global Long-Acting Contraceptive Pills Sales Market Share by Company (2021-2026)
3.2 Global Long-Acting Contraceptive Pills Annual Revenue by Company (2021-2026)
3.2.1 Global Long-Acting Contraceptive Pills Revenue by Company (2021-2026)
3.2.2 Global Long-Acting Contraceptive Pills Revenue Market Share by Company (2021-2026)
3.3 Global Long-Acting Contraceptive Pills Sale Price by Company
3.4 Key Manufacturers Long-Acting Contraceptive Pills Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Long-Acting Contraceptive Pills Product Location Distribution
3.4.2 Players Long-Acting Contraceptive Pills Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2024-2026)
3.6 New Products and Potential Entrants
3.7 Market M&A Activity & Strategy
4 WORLD HISTORIC REVIEW FOR LONG-ACTING CONTRACEPTIVE PILLS BY GEOGRAPHIC REGION
4.1 World Historic Long-Acting Contraceptive Pills Market Size by Geographic Region (2021-2026)
4.1.1 Global Long-Acting Contraceptive Pills Annual Sales by Geographic Region (2021-2026)
4.1.2 Global Long-Acting Contraceptive Pills Annual Revenue by Geographic Region (2021-2026)
4.2 World Historic Long-Acting Contraceptive Pills Market Size by Country/Region (2021-2026)
4.2.1 Global Long-Acting Contraceptive Pills Annual Sales by Country/Region (2021-2026)
4.2.2 Global Long-Acting Contraceptive Pills Annual Revenue by Country/Region (2021-2026)
4.3 Americas Long-Acting Contraceptive Pills Sales Growth
4.4 APAC Long-Acting Contraceptive Pills Sales Growth
4.5 Europe Long-Acting Contraceptive Pills Sales Growth
4.6 Middle East & Africa Long-Acting Contraceptive Pills Sales Growth
5 AMERICAS
5.1 Americas Long-Acting Contraceptive Pills Sales by Country
5.1.1 Americas Long-Acting Contraceptive Pills Sales by Country (2021-2026)
5.1.2 Americas Long-Acting Contraceptive Pills Revenue by Country (2021-2026)
5.2 Americas Long-Acting Contraceptive Pills Sales by Type (2021-2026)
5.3 Americas Long-Acting Contraceptive Pills Sales by Application (2021-2026)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Long-Acting Contraceptive Pills Sales by Region
6.1.1 APAC Long-Acting Contraceptive Pills Sales by Region (2021-2026)
6.1.2 APAC Long-Acting Contraceptive Pills Revenue by Region (2021-2026)
6.2 APAC Long-Acting Contraceptive Pills Sales by Type (2021-2026)
6.3 APAC Long-Acting Contraceptive Pills Sales by Application (2021-2026)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 EUROPE
7.1 Europe Long-Acting Contraceptive Pills by Country
7.1.1 Europe Long-Acting Contraceptive Pills Sales by Country (2021-2026)
7.1.2 Europe Long-Acting Contraceptive Pills Revenue by Country (2021-2026)
7.2 Europe Long-Acting Contraceptive Pills Sales by Type (2021-2026)
7.3 Europe Long-Acting Contraceptive Pills Sales by Application (2021-2026)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Long-Acting Contraceptive Pills by Country
8.1.1 Middle East & Africa Long-Acting Contraceptive Pills Sales by Country (2021-2026)
8.1.2 Middle East & Africa Long-Acting Contraceptive Pills Revenue by Country (2021-2026)
8.2 Middle East & Africa Long-Acting Contraceptive Pills Sales by Type (2021-2026)
8.3 Middle East & Africa Long-Acting Contraceptive Pills Sales by Application (2021-2026)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 MANUFACTURING COST STRUCTURE ANALYSIS
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Long-Acting Contraceptive Pills
10.3 Manufacturing Process Analysis of Long-Acting Contraceptive Pills
10.4 Industry Chain Structure of Long-Acting Contraceptive Pills
11 MARKETING, DISTRIBUTORS AND CUSTOMER
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Long-Acting Contraceptive Pills Distributors
11.3 Long-Acting Contraceptive Pills Customer
12 WORLD FORECAST REVIEW FOR LONG-ACTING CONTRACEPTIVE PILLS BY GEOGRAPHIC REGION
12.1 Global Long-Acting Contraceptive Pills Market Size Forecast by Region
12.1.1 Global Long-Acting Contraceptive Pills Forecast by Region (2027-2032)
12.1.2 Global Long-Acting Contraceptive Pills Annual Revenue Forecast by Region (2027-2032)
12.2 Americas Forecast by Country (2027-2032)
12.3 APAC Forecast by Region (2027-2032)
12.4 Europe Forecast by Country (2027-2032)
12.5 Middle East & Africa Forecast by Country (2027-2032)
12.6 Global Long-Acting Contraceptive Pills Forecast by Type (2027-2032)
12.7 Global Long-Acting Contraceptive Pills Forecast by Application (2027-2032)
13 KEY PLAYERS ANALYSIS
13.1 Zhejiang Xianju Pharmaceutical
13.1.1 Zhejiang Xianju Pharmaceutical Company Information
13.1.2 Zhejiang Xianju Pharmaceutical Long-Acting Contraceptive Pills Product Portfolios and Specifications
13.1.3 Zhejiang Xianju Pharmaceutical Long-Acting Contraceptive Pills Sales, Revenue, Price and Gross Margin (2021-2026)
13.1.4 Zhejiang Xianju Pharmaceutical Main Business Overview
13.1.5 Zhejiang Xianju Pharmaceutical Latest Developments
13.2 Pfizer
13.2.1 Pfizer Company Information
13.2.2 Pfizer Long-Acting Contraceptive Pills Product Portfolios and Specifications
13.2.3 Pfizer Long-Acting Contraceptive Pills Sales, Revenue, Price and Gross Margin (2021-2026)
13.2.4 Pfizer Main Business Overview
13.2.5 Pfizer Latest Developments
13.3 Mylan
13.3.1 Mylan Company Information
13.3.2 Mylan Long-Acting Contraceptive Pills Product Portfolios and Specifications
13.3.3 Mylan Long-Acting Contraceptive Pills Sales, Revenue, Price and Gross Margin (2021-2026)
13.3.4 Mylan Main Business Overview
13.3.5 Mylan Latest Developments
13.4 Teva Pharmaceuticals
13.4.1 Teva Pharmaceuticals Company Information
13.4.2 Teva Pharmaceuticals Long-Acting Contraceptive Pills Product Portfolios and Specifications
13.4.3 Teva Pharmaceuticals Long-Acting Contraceptive Pills Sales, Revenue, Price and Gross Margin (2021-2026)
13.4.4 Teva Pharmaceuticals Main Business Overview
13.4.5 Teva Pharmaceuticals Latest Developments
13.5 Cipla
13.5.1 Cipla Company Information
13.5.2 Cipla Long-Acting Contraceptive Pills Product Portfolios and Specifications
13.5.3 Cipla Long-Acting Contraceptive Pills Sales, Revenue, Price and Gross Margin (2021-2026)
13.5.4 Cipla Main Business Overview
13.5.5 Cipla Latest Developments
13.6 Bayer
13.6.1 Bayer Company Information
13.6.2 Bayer Long-Acting Contraceptive Pills Product Portfolios and Specifications
13.6.3 Bayer Long-Acting Contraceptive Pills Sales, Revenue, Price and Gross Margin (2021-2026)
13.6.4 Bayer Main Business Overview
13.6.5 Bayer Latest Developments
13.7 Merck
13.7.1 Merck Company Information
13.7.2 Merck Long-Acting Contraceptive Pills Product Portfolios and Specifications
13.7.3 Merck Long-Acting Contraceptive Pills Sales, Revenue, Price and Gross Margin (2021-2026)
13.7.4 Merck Main Business Overview
13.7.5 Merck Latest Developments
13.8 Sun Pharma
13.8.1 Sun Pharma Company Information
13.8.2 Sun Pharma Long-Acting Contraceptive Pills Product Portfolios and Specifications
13.8.3 Sun Pharma Long-Acting Contraceptive Pills Sales, Revenue, Price and Gross Margin (2021-2026)
13.8.4 Sun Pharma Main Business Overview
13.8.5 Sun Pharma Latest Developments
13.9 Shanghai Pharmaceuticals
13.9.1 Shanghai Pharmaceuticals Company Information
13.9.2 Shanghai Pharmaceuticals Long-Acting Contraceptive Pills Product Portfolios and Specifications
13.9.3 Shanghai Pharmaceuticals Long-Acting Contraceptive Pills Sales, Revenue, Price and Gross Margin (2021-2026)
13.9.4 Shanghai Pharmaceuticals Main Business Overview
13.9.5 Shanghai Pharmaceuticals Latest Developments
14 RESEARCH FINDINGS AND CONCLUSION
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Long-Acting Contraceptive Pills Annual Sales 2021-2032
2.1.2 World Current & Future Analysis for Long-Acting Contraceptive Pills by Geographic Region, 2021, 2025 & 2032
2.1.3 World Current & Future Analysis for Long-Acting Contraceptive Pills by Country/Region, 2021, 2025 & 2032
2.2 Long-Acting Contraceptive Pills Segment by Type
2.2.1 Injectables
2.2.2 Subdermal Implants
2.2.3 Intrauterine Devices
2.2.4 Other
2.2.5 Long-Acting Contraceptive Pills Sales by Type
2.2.5.1 Global Long-Acting Contraceptive Pills Sales Market Share by Type (2021-2026)
2.2.5.2 Global Long-Acting Contraceptive Pills Revenue and Market Share by Type (2021-2026)
2.2.5.3 Global Long-Acting Contraceptive Pills Sale Price by Type (2021-2026)
2.3 Long-Acting Contraceptive Pills Segment by Application
2.3.1 Hospital
2.3.2 Clinic
2.3.3 Long-Acting Contraceptive Pills Sales by Application
2.3.3.1 Global Long-Acting Contraceptive Pills Sale Market Share by Application (2021-2026)
2.3.3.2 Global Long-Acting Contraceptive Pills Revenue and Market Share by Application (2021-2026)
2.3.3.3 Global Long-Acting Contraceptive Pills Sale Price by Application (2021-2026)
3 GLOBAL BY COMPANY
3.1 Global Long-Acting Contraceptive Pills Breakdown Data by Company
3.1.1 Global Long-Acting Contraceptive Pills Annual Sales by Company (2021-2026)
3.1.2 Global Long-Acting Contraceptive Pills Sales Market Share by Company (2021-2026)
3.2 Global Long-Acting Contraceptive Pills Annual Revenue by Company (2021-2026)
3.2.1 Global Long-Acting Contraceptive Pills Revenue by Company (2021-2026)
3.2.2 Global Long-Acting Contraceptive Pills Revenue Market Share by Company (2021-2026)
3.3 Global Long-Acting Contraceptive Pills Sale Price by Company
3.4 Key Manufacturers Long-Acting Contraceptive Pills Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Long-Acting Contraceptive Pills Product Location Distribution
3.4.2 Players Long-Acting Contraceptive Pills Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2024-2026)
3.6 New Products and Potential Entrants
3.7 Market M&A Activity & Strategy
4 WORLD HISTORIC REVIEW FOR LONG-ACTING CONTRACEPTIVE PILLS BY GEOGRAPHIC REGION
4.1 World Historic Long-Acting Contraceptive Pills Market Size by Geographic Region (2021-2026)
4.1.1 Global Long-Acting Contraceptive Pills Annual Sales by Geographic Region (2021-2026)
4.1.2 Global Long-Acting Contraceptive Pills Annual Revenue by Geographic Region (2021-2026)
4.2 World Historic Long-Acting Contraceptive Pills Market Size by Country/Region (2021-2026)
4.2.1 Global Long-Acting Contraceptive Pills Annual Sales by Country/Region (2021-2026)
4.2.2 Global Long-Acting Contraceptive Pills Annual Revenue by Country/Region (2021-2026)
4.3 Americas Long-Acting Contraceptive Pills Sales Growth
4.4 APAC Long-Acting Contraceptive Pills Sales Growth
4.5 Europe Long-Acting Contraceptive Pills Sales Growth
4.6 Middle East & Africa Long-Acting Contraceptive Pills Sales Growth
5 AMERICAS
5.1 Americas Long-Acting Contraceptive Pills Sales by Country
5.1.1 Americas Long-Acting Contraceptive Pills Sales by Country (2021-2026)
5.1.2 Americas Long-Acting Contraceptive Pills Revenue by Country (2021-2026)
5.2 Americas Long-Acting Contraceptive Pills Sales by Type (2021-2026)
5.3 Americas Long-Acting Contraceptive Pills Sales by Application (2021-2026)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Long-Acting Contraceptive Pills Sales by Region
6.1.1 APAC Long-Acting Contraceptive Pills Sales by Region (2021-2026)
6.1.2 APAC Long-Acting Contraceptive Pills Revenue by Region (2021-2026)
6.2 APAC Long-Acting Contraceptive Pills Sales by Type (2021-2026)
6.3 APAC Long-Acting Contraceptive Pills Sales by Application (2021-2026)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 EUROPE
7.1 Europe Long-Acting Contraceptive Pills by Country
7.1.1 Europe Long-Acting Contraceptive Pills Sales by Country (2021-2026)
7.1.2 Europe Long-Acting Contraceptive Pills Revenue by Country (2021-2026)
7.2 Europe Long-Acting Contraceptive Pills Sales by Type (2021-2026)
7.3 Europe Long-Acting Contraceptive Pills Sales by Application (2021-2026)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Long-Acting Contraceptive Pills by Country
8.1.1 Middle East & Africa Long-Acting Contraceptive Pills Sales by Country (2021-2026)
8.1.2 Middle East & Africa Long-Acting Contraceptive Pills Revenue by Country (2021-2026)
8.2 Middle East & Africa Long-Acting Contraceptive Pills Sales by Type (2021-2026)
8.3 Middle East & Africa Long-Acting Contraceptive Pills Sales by Application (2021-2026)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 MANUFACTURING COST STRUCTURE ANALYSIS
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Long-Acting Contraceptive Pills
10.3 Manufacturing Process Analysis of Long-Acting Contraceptive Pills
10.4 Industry Chain Structure of Long-Acting Contraceptive Pills
11 MARKETING, DISTRIBUTORS AND CUSTOMER
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Long-Acting Contraceptive Pills Distributors
11.3 Long-Acting Contraceptive Pills Customer
12 WORLD FORECAST REVIEW FOR LONG-ACTING CONTRACEPTIVE PILLS BY GEOGRAPHIC REGION
12.1 Global Long-Acting Contraceptive Pills Market Size Forecast by Region
12.1.1 Global Long-Acting Contraceptive Pills Forecast by Region (2027-2032)
12.1.2 Global Long-Acting Contraceptive Pills Annual Revenue Forecast by Region (2027-2032)
12.2 Americas Forecast by Country (2027-2032)
12.3 APAC Forecast by Region (2027-2032)
12.4 Europe Forecast by Country (2027-2032)
12.5 Middle East & Africa Forecast by Country (2027-2032)
12.6 Global Long-Acting Contraceptive Pills Forecast by Type (2027-2032)
12.7 Global Long-Acting Contraceptive Pills Forecast by Application (2027-2032)
13 KEY PLAYERS ANALYSIS
13.1 Zhejiang Xianju Pharmaceutical
13.1.1 Zhejiang Xianju Pharmaceutical Company Information
13.1.2 Zhejiang Xianju Pharmaceutical Long-Acting Contraceptive Pills Product Portfolios and Specifications
13.1.3 Zhejiang Xianju Pharmaceutical Long-Acting Contraceptive Pills Sales, Revenue, Price and Gross Margin (2021-2026)
13.1.4 Zhejiang Xianju Pharmaceutical Main Business Overview
13.1.5 Zhejiang Xianju Pharmaceutical Latest Developments
13.2 Pfizer
13.2.1 Pfizer Company Information
13.2.2 Pfizer Long-Acting Contraceptive Pills Product Portfolios and Specifications
13.2.3 Pfizer Long-Acting Contraceptive Pills Sales, Revenue, Price and Gross Margin (2021-2026)
13.2.4 Pfizer Main Business Overview
13.2.5 Pfizer Latest Developments
13.3 Mylan
13.3.1 Mylan Company Information
13.3.2 Mylan Long-Acting Contraceptive Pills Product Portfolios and Specifications
13.3.3 Mylan Long-Acting Contraceptive Pills Sales, Revenue, Price and Gross Margin (2021-2026)
13.3.4 Mylan Main Business Overview
13.3.5 Mylan Latest Developments
13.4 Teva Pharmaceuticals
13.4.1 Teva Pharmaceuticals Company Information
13.4.2 Teva Pharmaceuticals Long-Acting Contraceptive Pills Product Portfolios and Specifications
13.4.3 Teva Pharmaceuticals Long-Acting Contraceptive Pills Sales, Revenue, Price and Gross Margin (2021-2026)
13.4.4 Teva Pharmaceuticals Main Business Overview
13.4.5 Teva Pharmaceuticals Latest Developments
13.5 Cipla
13.5.1 Cipla Company Information
13.5.2 Cipla Long-Acting Contraceptive Pills Product Portfolios and Specifications
13.5.3 Cipla Long-Acting Contraceptive Pills Sales, Revenue, Price and Gross Margin (2021-2026)
13.5.4 Cipla Main Business Overview
13.5.5 Cipla Latest Developments
13.6 Bayer
13.6.1 Bayer Company Information
13.6.2 Bayer Long-Acting Contraceptive Pills Product Portfolios and Specifications
13.6.3 Bayer Long-Acting Contraceptive Pills Sales, Revenue, Price and Gross Margin (2021-2026)
13.6.4 Bayer Main Business Overview
13.6.5 Bayer Latest Developments
13.7 Merck
13.7.1 Merck Company Information
13.7.2 Merck Long-Acting Contraceptive Pills Product Portfolios and Specifications
13.7.3 Merck Long-Acting Contraceptive Pills Sales, Revenue, Price and Gross Margin (2021-2026)
13.7.4 Merck Main Business Overview
13.7.5 Merck Latest Developments
13.8 Sun Pharma
13.8.1 Sun Pharma Company Information
13.8.2 Sun Pharma Long-Acting Contraceptive Pills Product Portfolios and Specifications
13.8.3 Sun Pharma Long-Acting Contraceptive Pills Sales, Revenue, Price and Gross Margin (2021-2026)
13.8.4 Sun Pharma Main Business Overview
13.8.5 Sun Pharma Latest Developments
13.9 Shanghai Pharmaceuticals
13.9.1 Shanghai Pharmaceuticals Company Information
13.9.2 Shanghai Pharmaceuticals Long-Acting Contraceptive Pills Product Portfolios and Specifications
13.9.3 Shanghai Pharmaceuticals Long-Acting Contraceptive Pills Sales, Revenue, Price and Gross Margin (2021-2026)
13.9.4 Shanghai Pharmaceuticals Main Business Overview
13.9.5 Shanghai Pharmaceuticals Latest Developments
14 RESEARCH FINDINGS AND CONCLUSION
LIST OF TABLES
Table 1. Long-Acting Contraceptive Pills Annual Sales CAGR by Geographic Region (2021, 2025 & 2032) & ($ millions)
Table 2. Long-Acting Contraceptive Pills Annual Sales CAGR by Country/Region (2021, 2025 & 2032) & ($ millions)
Table 3. Major Players of Injectables
Table 4. Major Players of Subdermal Implants
Table 5. Major Players of Intrauterine Devices
Table 6. Major Players of Other
Table 7. Global Long-Acting Contraceptive Pills Sales by Type (2021-2026) & (K Units)
Table 8. Global Long-Acting Contraceptive Pills Sales Market Share by Type (2021-2026)
Table 9. Global Long-Acting Contraceptive Pills Revenue by Type (2021-2026) & ($ million)
Table 10. Global Long-Acting Contraceptive Pills Revenue Market Share by Type (2021-2026)
Table 11. Global Long-Acting Contraceptive Pills Sale Price by Type (2021-2026) & (US$/Unit)
Table 12. Global Long-Acting Contraceptive Pills Sale by Application (2021-2026) & (K Units)
Table 13. Global Long-Acting Contraceptive Pills Sale Market Share by Application (2021-2026)
Table 14. Global Long-Acting Contraceptive Pills Revenue by Application (2021-2026) & ($ million)
Table 15. Global Long-Acting Contraceptive Pills Revenue Market Share by Application (2021-2026)
Table 16. Global Long-Acting Contraceptive Pills Sale Price by Application (2021-2026) & (US$/Unit)
Table 17. Global Long-Acting Contraceptive Pills Sales by Company (2021-2026) & (K Units)
Table 18. Global Long-Acting Contraceptive Pills Sales Market Share by Company (2021-2026)
Table 19. Global Long-Acting Contraceptive Pills Revenue by Company (2021-2026) & ($ millions)
Table 20. Global Long-Acting Contraceptive Pills Revenue Market Share by Company (2021-2026)
Table 21. Global Long-Acting Contraceptive Pills Sale Price by Company (2021-2026) & (US$/Unit)
Table 22. Key Manufacturers Long-Acting Contraceptive Pills Producing Area Distribution and Sales Area
Table 23. Players Long-Acting Contraceptive Pills Products Offered
Table 24. Long-Acting Contraceptive Pills Concentration Ratio (CR3, CR5 and CR10) & (2024-2026)
Table 25. New Products and Potential Entrants
Table 26. Market M&A Activity & Strategy
Table 27. Global Long-Acting Contraceptive Pills Sales by Geographic Region (2021-2026) & (K Units)
Table 28. Global Long-Acting Contraceptive Pills Sales Market Share Geographic Region (2021-2026)
Table 29. Global Long-Acting Contraceptive Pills Revenue by Geographic Region (2021-2026) & ($ millions)
Table 30. Global Long-Acting Contraceptive Pills Revenue Market Share by Geographic Region (2021-2026)
Table 31. Global Long-Acting Contraceptive Pills Sales by Country/Region (2021-2026) & (K Units)
Table 32. Global Long-Acting Contraceptive Pills Sales Market Share by Country/Region (2021-2026)
Table 33. Global Long-Acting Contraceptive Pills Revenue by Country/Region (2021-2026) & ($ millions)
Table 34. Global Long-Acting Contraceptive Pills Revenue Market Share by Country/Region (2021-2026)
Table 35. Americas Long-Acting Contraceptive Pills Sales by Country (2021-2026) & (K Units)
Table 36. Americas Long-Acting Contraceptive Pills Sales Market Share by Country (2021-2026)
Table 37. Americas Long-Acting Contraceptive Pills Revenue by Country (2021-2026) & ($ millions)
Table 38. Americas Long-Acting Contraceptive Pills Sales by Type (2021-2026) & (K Units)
Table 39. Americas Long-Acting Contraceptive Pills Sales by Application (2021-2026) & (K Units)
Table 40. APAC Long-Acting Contraceptive Pills Sales by Region (2021-2026) & (K Units)
Table 41. APAC Long-Acting Contraceptive Pills Sales Market Share by Region (2021-2026)
Table 42. APAC Long-Acting Contraceptive Pills Revenue by Region (2021-2026) & ($ millions)
Table 43. APAC Long-Acting Contraceptive Pills Sales by Type (2021-2026) & (K Units)
Table 44. APAC Long-Acting Contraceptive Pills Sales by Application (2021-2026) & (K Units)
Table 45. Europe Long-Acting Contraceptive Pills Sales by Country (2021-2026) & (K Units)
Table 46. Europe Long-Acting Contraceptive Pills Revenue by Country (2021-2026) & ($ millions)
Table 47. Europe Long-Acting Contraceptive Pills Sales by Type (2021-2026) & (K Units)
Table 48. Europe Long-Acting Contraceptive Pills Sales by Application (2021-2026) & (K Units)
Table 49. Middle East & Africa Long-Acting Contraceptive Pills Sales by Country (2021-2026) & (K Units)
Table 50. Middle East & Africa Long-Acting Contraceptive Pills Revenue Market Share by Country (2021-2026)
Table 51. Middle East & Africa Long-Acting Contraceptive Pills Sales by Type (2021-2026) & (K Units)
Table 52. Middle East & Africa Long-Acting Contraceptive Pills Sales by Application (2021-2026) & (K Units)
Table 53. Key Market Drivers & Growth Opportunities of Long-Acting Contraceptive Pills
Table 54. Key Market Challenges & Risks of Long-Acting Contraceptive Pills
Table 55. Key Industry Trends of Long-Acting Contraceptive Pills
Table 56. Long-Acting Contraceptive Pills Raw Material
Table 57. Key Suppliers of Raw Materials
Table 58. Long-Acting Contraceptive Pills Distributors List
Table 59. Long-Acting Contraceptive Pills Customer List
Table 60. Global Long-Acting Contraceptive Pills Sales Forecast by Region (2027-2032) & (K Units)
Table 61. Global Long-Acting Contraceptive Pills Revenue Forecast by Region (2027-2032) & ($ millions)
Table 62. Americas Long-Acting Contraceptive Pills Sales Forecast by Country (2027-2032) & (K Units)
Table 63. Americas Long-Acting Contraceptive Pills Annual Revenue Forecast by Country (2027-2032) & ($ millions)
Table 64. APAC Long-Acting Contraceptive Pills Sales Forecast by Region (2027-2032) & (K Units)
Table 65. APAC Long-Acting Contraceptive Pills Annual Revenue Forecast by Region (2027-2032) & ($ millions)
Table 66. Europe Long-Acting Contraceptive Pills Sales Forecast by Country (2027-2032) & (K Units)
Table 67. Europe Long-Acting Contraceptive Pills Revenue Forecast by Country (2027-2032) & ($ millions)
Table 68. Middle East & Africa Long-Acting Contraceptive Pills Sales Forecast by Country (2027-2032) & (K Units)
Table 69. Middle East & Africa Long-Acting Contraceptive Pills Revenue Forecast by Country (2027-2032) & ($ millions)
Table 70. Global Long-Acting Contraceptive Pills Sales Forecast by Type (2027-2032) & (K Units)
Table 71. Global Long-Acting Contraceptive Pills Revenue Forecast by Type (2027-2032) & ($ millions)
Table 72. Global Long-Acting Contraceptive Pills Sales Forecast by Application (2027-2032) & (K Units)
Table 73. Global Long-Acting Contraceptive Pills Revenue Forecast by Application (2027-2032) & ($ millions)
Table 74. Zhejiang Xianju Pharmaceutical Basic Information, Long-Acting Contraceptive Pills Manufacturing Base, Sales Area and Its Competitors
Table 75. Zhejiang Xianju Pharmaceutical Long-Acting Contraceptive Pills Product Portfolios and Specifications
Table 76. Zhejiang Xianju Pharmaceutical Long-Acting Contraceptive Pills Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 77. Zhejiang Xianju Pharmaceutical Main Business
Table 78. Zhejiang Xianju Pharmaceutical Latest Developments
Table 79. Pfizer Basic Information, Long-Acting Contraceptive Pills Manufacturing Base, Sales Area and Its Competitors
Table 80. Pfizer Long-Acting Contraceptive Pills Product Portfolios and Specifications
Table 81. Pfizer Long-Acting Contraceptive Pills Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 82. Pfizer Main Business
Table 83. Pfizer Latest Developments
Table 84. Mylan Basic Information, Long-Acting Contraceptive Pills Manufacturing Base, Sales Area and Its Competitors
Table 85. Mylan Long-Acting Contraceptive Pills Product Portfolios and Specifications
Table 86. Mylan Long-Acting Contraceptive Pills Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 87. Mylan Main Business
Table 88. Mylan Latest Developments
Table 89. Teva Pharmaceuticals Basic Information, Long-Acting Contraceptive Pills Manufacturing Base, Sales Area and Its Competitors
Table 90. Teva Pharmaceuticals Long-Acting Contraceptive Pills Product Portfolios and Specifications
Table 91. Teva Pharmaceuticals Long-Acting Contraceptive Pills Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 92. Teva Pharmaceuticals Main Business
Table 93. Teva Pharmaceuticals Latest Developments
Table 94. Cipla Basic Information, Long-Acting Contraceptive Pills Manufacturing Base, Sales Area and Its Competitors
Table 95. Cipla Long-Acting Contraceptive Pills Product Portfolios and Specifications
Table 96. Cipla Long-Acting Contraceptive Pills Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 97. Cipla Main Business
Table 98. Cipla Latest Developments
Table 99. Bayer Basic Information, Long-Acting Contraceptive Pills Manufacturing Base, Sales Area and Its Competitors
Table 100. Bayer Long-Acting Contraceptive Pills Product Portfolios and Specifications
Table 101. Bayer Long-Acting Contraceptive Pills Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 102. Bayer Main Business
Table 103. Bayer Latest Developments
Table 104. Merck Basic Information, Long-Acting Contraceptive Pills Manufacturing Base, Sales Area and Its Competitors
Table 105. Merck Long-Acting Contraceptive Pills Product Portfolios and Specifications
Table 106. Merck Long-Acting Contraceptive Pills Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 107. Merck Main Business
Table 108. Merck Latest Developments
Table 109. Sun Pharma Basic Information, Long-Acting Contraceptive Pills Manufacturing Base, Sales Area and Its Competitors
Table 110. Sun Pharma Long-Acting Contraceptive Pills Product Portfolios and Specifications
Table 111. Sun Pharma Long-Acting Contraceptive Pills Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 112. Sun Pharma Main Business
Table 113. Sun Pharma Latest Developments
Table 114. Shanghai Pharmaceuticals Basic Information, Long-Acting Contraceptive Pills Manufacturing Base, Sales Area and Its Competitors
Table 115. Shanghai Pharmaceuticals Long-Acting Contraceptive Pills Product Portfolios and Specifications
Table 116. Shanghai Pharmaceuticals Long-Acting Contraceptive Pills Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 117. Shanghai Pharmaceuticals Main Business
Table 118. Shanghai Pharmaceuticals Latest Developments
Table 1. Long-Acting Contraceptive Pills Annual Sales CAGR by Geographic Region (2021, 2025 & 2032) & ($ millions)
Table 2. Long-Acting Contraceptive Pills Annual Sales CAGR by Country/Region (2021, 2025 & 2032) & ($ millions)
Table 3. Major Players of Injectables
Table 4. Major Players of Subdermal Implants
Table 5. Major Players of Intrauterine Devices
Table 6. Major Players of Other
Table 7. Global Long-Acting Contraceptive Pills Sales by Type (2021-2026) & (K Units)
Table 8. Global Long-Acting Contraceptive Pills Sales Market Share by Type (2021-2026)
Table 9. Global Long-Acting Contraceptive Pills Revenue by Type (2021-2026) & ($ million)
Table 10. Global Long-Acting Contraceptive Pills Revenue Market Share by Type (2021-2026)
Table 11. Global Long-Acting Contraceptive Pills Sale Price by Type (2021-2026) & (US$/Unit)
Table 12. Global Long-Acting Contraceptive Pills Sale by Application (2021-2026) & (K Units)
Table 13. Global Long-Acting Contraceptive Pills Sale Market Share by Application (2021-2026)
Table 14. Global Long-Acting Contraceptive Pills Revenue by Application (2021-2026) & ($ million)
Table 15. Global Long-Acting Contraceptive Pills Revenue Market Share by Application (2021-2026)
Table 16. Global Long-Acting Contraceptive Pills Sale Price by Application (2021-2026) & (US$/Unit)
Table 17. Global Long-Acting Contraceptive Pills Sales by Company (2021-2026) & (K Units)
Table 18. Global Long-Acting Contraceptive Pills Sales Market Share by Company (2021-2026)
Table 19. Global Long-Acting Contraceptive Pills Revenue by Company (2021-2026) & ($ millions)
Table 20. Global Long-Acting Contraceptive Pills Revenue Market Share by Company (2021-2026)
Table 21. Global Long-Acting Contraceptive Pills Sale Price by Company (2021-2026) & (US$/Unit)
Table 22. Key Manufacturers Long-Acting Contraceptive Pills Producing Area Distribution and Sales Area
Table 23. Players Long-Acting Contraceptive Pills Products Offered
Table 24. Long-Acting Contraceptive Pills Concentration Ratio (CR3, CR5 and CR10) & (2024-2026)
Table 25. New Products and Potential Entrants
Table 26. Market M&A Activity & Strategy
Table 27. Global Long-Acting Contraceptive Pills Sales by Geographic Region (2021-2026) & (K Units)
Table 28. Global Long-Acting Contraceptive Pills Sales Market Share Geographic Region (2021-2026)
Table 29. Global Long-Acting Contraceptive Pills Revenue by Geographic Region (2021-2026) & ($ millions)
Table 30. Global Long-Acting Contraceptive Pills Revenue Market Share by Geographic Region (2021-2026)
Table 31. Global Long-Acting Contraceptive Pills Sales by Country/Region (2021-2026) & (K Units)
Table 32. Global Long-Acting Contraceptive Pills Sales Market Share by Country/Region (2021-2026)
Table 33. Global Long-Acting Contraceptive Pills Revenue by Country/Region (2021-2026) & ($ millions)
Table 34. Global Long-Acting Contraceptive Pills Revenue Market Share by Country/Region (2021-2026)
Table 35. Americas Long-Acting Contraceptive Pills Sales by Country (2021-2026) & (K Units)
Table 36. Americas Long-Acting Contraceptive Pills Sales Market Share by Country (2021-2026)
Table 37. Americas Long-Acting Contraceptive Pills Revenue by Country (2021-2026) & ($ millions)
Table 38. Americas Long-Acting Contraceptive Pills Sales by Type (2021-2026) & (K Units)
Table 39. Americas Long-Acting Contraceptive Pills Sales by Application (2021-2026) & (K Units)
Table 40. APAC Long-Acting Contraceptive Pills Sales by Region (2021-2026) & (K Units)
Table 41. APAC Long-Acting Contraceptive Pills Sales Market Share by Region (2021-2026)
Table 42. APAC Long-Acting Contraceptive Pills Revenue by Region (2021-2026) & ($ millions)
Table 43. APAC Long-Acting Contraceptive Pills Sales by Type (2021-2026) & (K Units)
Table 44. APAC Long-Acting Contraceptive Pills Sales by Application (2021-2026) & (K Units)
Table 45. Europe Long-Acting Contraceptive Pills Sales by Country (2021-2026) & (K Units)
Table 46. Europe Long-Acting Contraceptive Pills Revenue by Country (2021-2026) & ($ millions)
Table 47. Europe Long-Acting Contraceptive Pills Sales by Type (2021-2026) & (K Units)
Table 48. Europe Long-Acting Contraceptive Pills Sales by Application (2021-2026) & (K Units)
Table 49. Middle East & Africa Long-Acting Contraceptive Pills Sales by Country (2021-2026) & (K Units)
Table 50. Middle East & Africa Long-Acting Contraceptive Pills Revenue Market Share by Country (2021-2026)
Table 51. Middle East & Africa Long-Acting Contraceptive Pills Sales by Type (2021-2026) & (K Units)
Table 52. Middle East & Africa Long-Acting Contraceptive Pills Sales by Application (2021-2026) & (K Units)
Table 53. Key Market Drivers & Growth Opportunities of Long-Acting Contraceptive Pills
Table 54. Key Market Challenges & Risks of Long-Acting Contraceptive Pills
Table 55. Key Industry Trends of Long-Acting Contraceptive Pills
Table 56. Long-Acting Contraceptive Pills Raw Material
Table 57. Key Suppliers of Raw Materials
Table 58. Long-Acting Contraceptive Pills Distributors List
Table 59. Long-Acting Contraceptive Pills Customer List
Table 60. Global Long-Acting Contraceptive Pills Sales Forecast by Region (2027-2032) & (K Units)
Table 61. Global Long-Acting Contraceptive Pills Revenue Forecast by Region (2027-2032) & ($ millions)
Table 62. Americas Long-Acting Contraceptive Pills Sales Forecast by Country (2027-2032) & (K Units)
Table 63. Americas Long-Acting Contraceptive Pills Annual Revenue Forecast by Country (2027-2032) & ($ millions)
Table 64. APAC Long-Acting Contraceptive Pills Sales Forecast by Region (2027-2032) & (K Units)
Table 65. APAC Long-Acting Contraceptive Pills Annual Revenue Forecast by Region (2027-2032) & ($ millions)
Table 66. Europe Long-Acting Contraceptive Pills Sales Forecast by Country (2027-2032) & (K Units)
Table 67. Europe Long-Acting Contraceptive Pills Revenue Forecast by Country (2027-2032) & ($ millions)
Table 68. Middle East & Africa Long-Acting Contraceptive Pills Sales Forecast by Country (2027-2032) & (K Units)
Table 69. Middle East & Africa Long-Acting Contraceptive Pills Revenue Forecast by Country (2027-2032) & ($ millions)
Table 70. Global Long-Acting Contraceptive Pills Sales Forecast by Type (2027-2032) & (K Units)
Table 71. Global Long-Acting Contraceptive Pills Revenue Forecast by Type (2027-2032) & ($ millions)
Table 72. Global Long-Acting Contraceptive Pills Sales Forecast by Application (2027-2032) & (K Units)
Table 73. Global Long-Acting Contraceptive Pills Revenue Forecast by Application (2027-2032) & ($ millions)
Table 74. Zhejiang Xianju Pharmaceutical Basic Information, Long-Acting Contraceptive Pills Manufacturing Base, Sales Area and Its Competitors
Table 75. Zhejiang Xianju Pharmaceutical Long-Acting Contraceptive Pills Product Portfolios and Specifications
Table 76. Zhejiang Xianju Pharmaceutical Long-Acting Contraceptive Pills Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 77. Zhejiang Xianju Pharmaceutical Main Business
Table 78. Zhejiang Xianju Pharmaceutical Latest Developments
Table 79. Pfizer Basic Information, Long-Acting Contraceptive Pills Manufacturing Base, Sales Area and Its Competitors
Table 80. Pfizer Long-Acting Contraceptive Pills Product Portfolios and Specifications
Table 81. Pfizer Long-Acting Contraceptive Pills Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 82. Pfizer Main Business
Table 83. Pfizer Latest Developments
Table 84. Mylan Basic Information, Long-Acting Contraceptive Pills Manufacturing Base, Sales Area and Its Competitors
Table 85. Mylan Long-Acting Contraceptive Pills Product Portfolios and Specifications
Table 86. Mylan Long-Acting Contraceptive Pills Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 87. Mylan Main Business
Table 88. Mylan Latest Developments
Table 89. Teva Pharmaceuticals Basic Information, Long-Acting Contraceptive Pills Manufacturing Base, Sales Area and Its Competitors
Table 90. Teva Pharmaceuticals Long-Acting Contraceptive Pills Product Portfolios and Specifications
Table 91. Teva Pharmaceuticals Long-Acting Contraceptive Pills Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 92. Teva Pharmaceuticals Main Business
Table 93. Teva Pharmaceuticals Latest Developments
Table 94. Cipla Basic Information, Long-Acting Contraceptive Pills Manufacturing Base, Sales Area and Its Competitors
Table 95. Cipla Long-Acting Contraceptive Pills Product Portfolios and Specifications
Table 96. Cipla Long-Acting Contraceptive Pills Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 97. Cipla Main Business
Table 98. Cipla Latest Developments
Table 99. Bayer Basic Information, Long-Acting Contraceptive Pills Manufacturing Base, Sales Area and Its Competitors
Table 100. Bayer Long-Acting Contraceptive Pills Product Portfolios and Specifications
Table 101. Bayer Long-Acting Contraceptive Pills Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 102. Bayer Main Business
Table 103. Bayer Latest Developments
Table 104. Merck Basic Information, Long-Acting Contraceptive Pills Manufacturing Base, Sales Area and Its Competitors
Table 105. Merck Long-Acting Contraceptive Pills Product Portfolios and Specifications
Table 106. Merck Long-Acting Contraceptive Pills Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 107. Merck Main Business
Table 108. Merck Latest Developments
Table 109. Sun Pharma Basic Information, Long-Acting Contraceptive Pills Manufacturing Base, Sales Area and Its Competitors
Table 110. Sun Pharma Long-Acting Contraceptive Pills Product Portfolios and Specifications
Table 111. Sun Pharma Long-Acting Contraceptive Pills Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 112. Sun Pharma Main Business
Table 113. Sun Pharma Latest Developments
Table 114. Shanghai Pharmaceuticals Basic Information, Long-Acting Contraceptive Pills Manufacturing Base, Sales Area and Its Competitors
Table 115. Shanghai Pharmaceuticals Long-Acting Contraceptive Pills Product Portfolios and Specifications
Table 116. Shanghai Pharmaceuticals Long-Acting Contraceptive Pills Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 117. Shanghai Pharmaceuticals Main Business
Table 118. Shanghai Pharmaceuticals Latest Developments
LIST OF FIGURES
Figure 1. Picture of Long-Acting Contraceptive Pills
Figure 2. Long-Acting Contraceptive Pills Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Long-Acting Contraceptive Pills Sales Growth Rate 2021-2032 (K Units)
Figure 7. Global Long-Acting Contraceptive Pills Revenue Growth Rate 2021-2032 ($ millions)
Figure 8. Long-Acting Contraceptive Pills Sales by Geographic Region (2021, 2025 & 2032) & ($ millions)
Figure 9. Long-Acting Contraceptive Pills Sales Market Share by Country/Region (2025)
Figure 10. Long-Acting Contraceptive Pills Sales Market Share by Country/Region (2021, 2025 & 2032)
Figure 11. Product Picture of Injectables
Figure 12. Product Picture of Subdermal Implants
Figure 13. Product Picture of Intrauterine Devices
Figure 14. Product Picture of Other
Figure 15. Global Long-Acting Contraceptive Pills Sales Market Share by Type in 2026
Figure 16. Global Long-Acting Contraceptive Pills Revenue Market Share by Type (2021-2026)
Figure 17. Long-Acting Contraceptive Pills Consumed in Hospital
Figure 18. Global Long-Acting Contraceptive Pills Market: Hospital (2021-2026) & (K Units)
Figure 19. Long-Acting Contraceptive Pills Consumed in Clinic
Figure 20. Global Long-Acting Contraceptive Pills Market: Clinic (2021-2026) & (K Units)
Figure 21. Global Long-Acting Contraceptive Pills Sale Market Share by Application (2025)
Figure 22. Global Long-Acting Contraceptive Pills Revenue Market Share by Application in 2026
Figure 23. Long-Acting Contraceptive Pills Sales by Company in 2026 (K Units)
Figure 24. Global Long-Acting Contraceptive Pills Sales Market Share by Company in 2026
Figure 25. Long-Acting Contraceptive Pills Revenue by Company in 2026 ($ millions)
Figure 26. Global Long-Acting Contraceptive Pills Revenue Market Share by Company in 2026
Figure 27. Global Long-Acting Contraceptive Pills Sales Market Share by Geographic Region (2021-2026)
Figure 28. Global Long-Acting Contraceptive Pills Revenue Market Share by Geographic Region in 2026
Figure 29. Americas Long-Acting Contraceptive Pills Sales 2021-2026 (K Units)
Figure 30. Americas Long-Acting Contraceptive Pills Revenue 2021-2026 ($ millions)
Figure 31. APAC Long-Acting Contraceptive Pills Sales 2021-2026 (K Units)
Figure 32. APAC Long-Acting Contraceptive Pills Revenue 2021-2026 ($ millions)
Figure 33. Europe Long-Acting Contraceptive Pills Sales 2021-2026 (K Units)
Figure 34. Europe Long-Acting Contraceptive Pills Revenue 2021-2026 ($ millions)
Figure 35. Middle East & Africa Long-Acting Contraceptive Pills Sales 2021-2026 (K Units)
Figure 36. Middle East & Africa Long-Acting Contraceptive Pills Revenue 2021-2026 ($ millions)
Figure 37. Americas Long-Acting Contraceptive Pills Sales Market Share by Country in 2026
Figure 38. Americas Long-Acting Contraceptive Pills Revenue Market Share by Country (2021-2026)
Figure 39. Americas Long-Acting Contraceptive Pills Sales Market Share by Type (2021-2026)
Figure 40. Americas Long-Acting Contraceptive Pills Sales Market Share by Application (2021-2026)
Figure 41. United States Long-Acting Contraceptive Pills Revenue Growth 2021-2026 ($ millions)
Figure 42. Canada Long-Acting Contraceptive Pills Revenue Growth 2021-2026 ($ millions)
Figure 43. Mexico Long-Acting Contraceptive Pills Revenue Growth 2021-2026 ($ millions)
Figure 44. Brazil Long-Acting Contraceptive Pills Revenue Growth 2021-2026 ($ millions)
Figure 45. APAC Long-Acting Contraceptive Pills Sales Market Share by Region in 2026
Figure 46. APAC Long-Acting Contraceptive Pills Revenue Market Share by Region (2021-2026)
Figure 47. APAC Long-Acting Contraceptive Pills Sales Market Share by Type (2021-2026)
Figure 48. APAC Long-Acting Contraceptive Pills Sales Market Share by Application (2021-2026)
Figure 49. China Long-Acting Contraceptive Pills Revenue Growth 2021-2026 ($ millions)
Figure 50. Japan Long-Acting Contraceptive Pills Revenue Growth 2021-2026 ($ millions)
Figure 51. South Korea Long-Acting Contraceptive Pills Revenue Growth 2021-2026 ($ millions)
Figure 52. Southeast Asia Long-Acting Contraceptive Pills Revenue Growth 2021-2026 ($ millions)
Figure 53. India Long-Acting Contraceptive Pills Revenue Growth 2021-2026 ($ millions)
Figure 54. Australia Long-Acting Contraceptive Pills Revenue Growth 2021-2026 ($ millions)
Figure 55. China Taiwan Long-Acting Contraceptive Pills Revenue Growth 2021-2026 ($ millions)
Figure 56. Europe Long-Acting Contraceptive Pills Sales Market Share by Country in 2026
Figure 57. Europe Long-Acting Contraceptive Pills Revenue Market Share by Country (2021-2026)
Figure 58. Europe Long-Acting Contraceptive Pills Sales Market Share by Type (2021-2026)
Figure 59. Europe Long-Acting Contraceptive Pills Sales Market Share by Application (2021-2026)
Figure 60. Germany Long-Acting Contraceptive Pills Revenue Growth 2021-2026 ($ millions)
Figure 61. France Long-Acting Contraceptive Pills Revenue Growth 2021-2026 ($ millions)
Figure 62. UK Long-Acting Contraceptive Pills Revenue Growth 2021-2026 ($ millions)
Figure 63. Italy Long-Acting Contraceptive Pills Revenue Growth 2021-2026 ($ millions)
Figure 64. Russia Long-Acting Contraceptive Pills Revenue Growth 2021-2026 ($ millions)
Figure 65. Middle East & Africa Long-Acting Contraceptive Pills Sales Market Share by Country (2021-2026)
Figure 66. Middle East & Africa Long-Acting Contraceptive Pills Sales Market Share by Type (2021-2026)
Figure 67. Middle East & Africa Long-Acting Contraceptive Pills Sales Market Share by Application (2021-2026)
Figure 68. Egypt Long-Acting Contraceptive Pills Revenue Growth 2021-2026 ($ millions)
Figure 69. South Africa Long-Acting Contraceptive Pills Revenue Growth 2021-2026 ($ millions)
Figure 70. Israel Long-Acting Contraceptive Pills Revenue Growth 2021-2026 ($ millions)
Figure 71. Turkey Long-Acting Contraceptive Pills Revenue Growth 2021-2026 ($ millions)
Figure 72. GCC Countries Long-Acting Contraceptive Pills Revenue Growth 2021-2026 ($ millions)
Figure 73. Manufacturing Cost Structure Analysis of Long-Acting Contraceptive Pills in 2026
Figure 74. Manufacturing Process Analysis of Long-Acting Contraceptive Pills
Figure 75. Industry Chain Structure of Long-Acting Contraceptive Pills
Figure 76. Channels of Distribution
Figure 77. Global Long-Acting Contraceptive Pills Sales Market Forecast by Region (2027-2032)
Figure 78. Global Long-Acting Contraceptive Pills Revenue Market Share Forecast by Region (2027-2032)
Figure 79. Global Long-Acting Contraceptive Pills Sales Market Share Forecast by Type (2027-2032)
Figure 80. Global Long-Acting Contraceptive Pills Revenue Market Share Forecast by Type (2027-2032)
Figure 81. Global Long-Acting Contraceptive Pills Sales Market Share Forecast by Application (2027-2032)
Figure 82. Global Long-Acting Contraceptive Pills Revenue Market Share Forecast by Application (2027-2032)
Figure 1. Picture of Long-Acting Contraceptive Pills
Figure 2. Long-Acting Contraceptive Pills Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Long-Acting Contraceptive Pills Sales Growth Rate 2021-2032 (K Units)
Figure 7. Global Long-Acting Contraceptive Pills Revenue Growth Rate 2021-2032 ($ millions)
Figure 8. Long-Acting Contraceptive Pills Sales by Geographic Region (2021, 2025 & 2032) & ($ millions)
Figure 9. Long-Acting Contraceptive Pills Sales Market Share by Country/Region (2025)
Figure 10. Long-Acting Contraceptive Pills Sales Market Share by Country/Region (2021, 2025 & 2032)
Figure 11. Product Picture of Injectables
Figure 12. Product Picture of Subdermal Implants
Figure 13. Product Picture of Intrauterine Devices
Figure 14. Product Picture of Other
Figure 15. Global Long-Acting Contraceptive Pills Sales Market Share by Type in 2026
Figure 16. Global Long-Acting Contraceptive Pills Revenue Market Share by Type (2021-2026)
Figure 17. Long-Acting Contraceptive Pills Consumed in Hospital
Figure 18. Global Long-Acting Contraceptive Pills Market: Hospital (2021-2026) & (K Units)
Figure 19. Long-Acting Contraceptive Pills Consumed in Clinic
Figure 20. Global Long-Acting Contraceptive Pills Market: Clinic (2021-2026) & (K Units)
Figure 21. Global Long-Acting Contraceptive Pills Sale Market Share by Application (2025)
Figure 22. Global Long-Acting Contraceptive Pills Revenue Market Share by Application in 2026
Figure 23. Long-Acting Contraceptive Pills Sales by Company in 2026 (K Units)
Figure 24. Global Long-Acting Contraceptive Pills Sales Market Share by Company in 2026
Figure 25. Long-Acting Contraceptive Pills Revenue by Company in 2026 ($ millions)
Figure 26. Global Long-Acting Contraceptive Pills Revenue Market Share by Company in 2026
Figure 27. Global Long-Acting Contraceptive Pills Sales Market Share by Geographic Region (2021-2026)
Figure 28. Global Long-Acting Contraceptive Pills Revenue Market Share by Geographic Region in 2026
Figure 29. Americas Long-Acting Contraceptive Pills Sales 2021-2026 (K Units)
Figure 30. Americas Long-Acting Contraceptive Pills Revenue 2021-2026 ($ millions)
Figure 31. APAC Long-Acting Contraceptive Pills Sales 2021-2026 (K Units)
Figure 32. APAC Long-Acting Contraceptive Pills Revenue 2021-2026 ($ millions)
Figure 33. Europe Long-Acting Contraceptive Pills Sales 2021-2026 (K Units)
Figure 34. Europe Long-Acting Contraceptive Pills Revenue 2021-2026 ($ millions)
Figure 35. Middle East & Africa Long-Acting Contraceptive Pills Sales 2021-2026 (K Units)
Figure 36. Middle East & Africa Long-Acting Contraceptive Pills Revenue 2021-2026 ($ millions)
Figure 37. Americas Long-Acting Contraceptive Pills Sales Market Share by Country in 2026
Figure 38. Americas Long-Acting Contraceptive Pills Revenue Market Share by Country (2021-2026)
Figure 39. Americas Long-Acting Contraceptive Pills Sales Market Share by Type (2021-2026)
Figure 40. Americas Long-Acting Contraceptive Pills Sales Market Share by Application (2021-2026)
Figure 41. United States Long-Acting Contraceptive Pills Revenue Growth 2021-2026 ($ millions)
Figure 42. Canada Long-Acting Contraceptive Pills Revenue Growth 2021-2026 ($ millions)
Figure 43. Mexico Long-Acting Contraceptive Pills Revenue Growth 2021-2026 ($ millions)
Figure 44. Brazil Long-Acting Contraceptive Pills Revenue Growth 2021-2026 ($ millions)
Figure 45. APAC Long-Acting Contraceptive Pills Sales Market Share by Region in 2026
Figure 46. APAC Long-Acting Contraceptive Pills Revenue Market Share by Region (2021-2026)
Figure 47. APAC Long-Acting Contraceptive Pills Sales Market Share by Type (2021-2026)
Figure 48. APAC Long-Acting Contraceptive Pills Sales Market Share by Application (2021-2026)
Figure 49. China Long-Acting Contraceptive Pills Revenue Growth 2021-2026 ($ millions)
Figure 50. Japan Long-Acting Contraceptive Pills Revenue Growth 2021-2026 ($ millions)
Figure 51. South Korea Long-Acting Contraceptive Pills Revenue Growth 2021-2026 ($ millions)
Figure 52. Southeast Asia Long-Acting Contraceptive Pills Revenue Growth 2021-2026 ($ millions)
Figure 53. India Long-Acting Contraceptive Pills Revenue Growth 2021-2026 ($ millions)
Figure 54. Australia Long-Acting Contraceptive Pills Revenue Growth 2021-2026 ($ millions)
Figure 55. China Taiwan Long-Acting Contraceptive Pills Revenue Growth 2021-2026 ($ millions)
Figure 56. Europe Long-Acting Contraceptive Pills Sales Market Share by Country in 2026
Figure 57. Europe Long-Acting Contraceptive Pills Revenue Market Share by Country (2021-2026)
Figure 58. Europe Long-Acting Contraceptive Pills Sales Market Share by Type (2021-2026)
Figure 59. Europe Long-Acting Contraceptive Pills Sales Market Share by Application (2021-2026)
Figure 60. Germany Long-Acting Contraceptive Pills Revenue Growth 2021-2026 ($ millions)
Figure 61. France Long-Acting Contraceptive Pills Revenue Growth 2021-2026 ($ millions)
Figure 62. UK Long-Acting Contraceptive Pills Revenue Growth 2021-2026 ($ millions)
Figure 63. Italy Long-Acting Contraceptive Pills Revenue Growth 2021-2026 ($ millions)
Figure 64. Russia Long-Acting Contraceptive Pills Revenue Growth 2021-2026 ($ millions)
Figure 65. Middle East & Africa Long-Acting Contraceptive Pills Sales Market Share by Country (2021-2026)
Figure 66. Middle East & Africa Long-Acting Contraceptive Pills Sales Market Share by Type (2021-2026)
Figure 67. Middle East & Africa Long-Acting Contraceptive Pills Sales Market Share by Application (2021-2026)
Figure 68. Egypt Long-Acting Contraceptive Pills Revenue Growth 2021-2026 ($ millions)
Figure 69. South Africa Long-Acting Contraceptive Pills Revenue Growth 2021-2026 ($ millions)
Figure 70. Israel Long-Acting Contraceptive Pills Revenue Growth 2021-2026 ($ millions)
Figure 71. Turkey Long-Acting Contraceptive Pills Revenue Growth 2021-2026 ($ millions)
Figure 72. GCC Countries Long-Acting Contraceptive Pills Revenue Growth 2021-2026 ($ millions)
Figure 73. Manufacturing Cost Structure Analysis of Long-Acting Contraceptive Pills in 2026
Figure 74. Manufacturing Process Analysis of Long-Acting Contraceptive Pills
Figure 75. Industry Chain Structure of Long-Acting Contraceptive Pills
Figure 76. Channels of Distribution
Figure 77. Global Long-Acting Contraceptive Pills Sales Market Forecast by Region (2027-2032)
Figure 78. Global Long-Acting Contraceptive Pills Revenue Market Share Forecast by Region (2027-2032)
Figure 79. Global Long-Acting Contraceptive Pills Sales Market Share Forecast by Type (2027-2032)
Figure 80. Global Long-Acting Contraceptive Pills Revenue Market Share Forecast by Type (2027-2032)
Figure 81. Global Long-Acting Contraceptive Pills Sales Market Share Forecast by Application (2027-2032)
Figure 82. Global Long-Acting Contraceptive Pills Revenue Market Share Forecast by Application (2027-2032)
